What is Pao Group Inc?
focuses on alternative patient care treatments.
PAOG · Verdict
Solid reward · low risk
PAOG scores well on cash flow and volatility with no major weaknesses flagged in the model.
Based on 88% data coverage
PAOG · Verdict
Top decile vs peers
Top decile vs peers
Top decile vs peers
Above average
Model-based scoring. For information only — not financial advice.
focuses on alternative patient care treatments. The company, through its subsidiaries, engages in the development, sale, and distribution of premium medical cannabis products for treatment of chronic and terminal patients. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 955.09K.
The scoring profile indicates moderate reward potential, with growth and valuation as the leading contributors. Risk indicators are low, suggesting a relatively contained downside profile.
For informational purposes only. Not financial advice.